Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Strick

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|April 15, 1994
Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1A K Debnath, S Jiang, N Strick, et al.
Peptide Research|July 1, 1992
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136)M W Pride, Y M Thanavala, N Strick, et al.
Molecular Immunology|September 1, 1991
Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nefA R Neurath, N Strick, H Kolbe, et al.
Journal of Molecular Recognition : JMR|September 1, 1995
Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxisA R Neurath, A K Debnath, N Strick, et al.
Nature Medicine|February 1, 1996
Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIVA R Neurath, S Jiang, N Strick, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammationR N Fichorova, F Zhou, V Ratnam, et al.
AIDS Research and Human Retroviruses|October 1, 1991
Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteinsA R Neurath, S Jiang, N Strick, et al.
The Journal of General Virology|June 1, 1980
An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitisA R Neurath, C E Stevens, N Strick, et al.
Journal of Virological Methods|December 1, 1985
Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccinesA R Neurath, N Strick, S B Kent, et al.
Vaccine|March 1, 1986
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizingA R Neurath, S B Kent, K Parker, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|April 15, 1994
Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1A K Debnath, S Jiang, N Strick, et al.
Peptide Research|July 1, 1992
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136)M W Pride, Y M Thanavala, N Strick, et al.
Molecular Immunology|September 1, 1991
Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nefA R Neurath, N Strick, H Kolbe, et al.
Journal of Molecular Recognition : JMR|September 1, 1995
Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxisA R Neurath, A K Debnath, N Strick, et al.
Nature Medicine|February 1, 1996
Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIVA R Neurath, S Jiang, N Strick, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammationR N Fichorova, F Zhou, V Ratnam, et al.
AIDS Research and Human Retroviruses|October 1, 1991
Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteinsA R Neurath, S Jiang, N Strick, et al.
The Journal of General Virology|June 1, 1980
An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitisA R Neurath, C E Stevens, N Strick, et al.
Journal of Virological Methods|December 1, 1985
Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccinesA R Neurath, N Strick, S B Kent, et al.
Vaccine|March 1, 1986
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizingA R Neurath, S B Kent, K Parker, et al.
Pageof 9